Fundz

Fundz Deep Dive

Everything you need to win SciRhom GmbH — in one platform.

Who to reach, what to say, and why now on SciRhom GmbH — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on SciRhom GmbH — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

SciRhom Secures EUR 63 Million Series A Financing Round to Accelerate iRhom2-targeting Therapies in Autoimmune Diseases

Jul 09, 2024•almost 2 years ago

Contract Type

partnership

MunichBiotechnologyHealth CareTherapeuticsBiopharma

Description

SciRhom GmbH has announced the closing of a EUR 63 million (USD 70 million) Series A financing round. The funding, co-led by Andera Partners, Kurma Partners, Hadean Ventures, MIG Capital, and Wellington Partners, with participation from other investors, will be used to accelerate and broaden the impact of the company’s innovative therapeutic strategy in autoimmune disorders.

Company Information

Company

SciRhom GmbH

Location

Munich, Bavaria, Germany

About

SciRhom GmbH is a biopharmaceutical company pioneering the development of first-in-class therapeutic iRhom2 antibodies, with a mission to provide a new treatment paradigm for autoimmune diseases.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for SciRhom GmbH's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.